[Use of cardiac glycosides of strophanthin-like action in the pharmacotherapy of chronic circulatory insufficiency].
D000255:Adenosine Triphosphate / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D002301:Cardiac Glycosides / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009277:Nandrolone / Q000031:analogs & derivatives / Q000627:therapeutic use; D010666:Phenylpropionates / Q000627:therapeutic use; D010946:Plants, Medicinal; D010952:Plasma Substitutes / Q000627:therapeutic use; D012214:Rheumatic Heart Disease / Q000188:drug therapy; D013328:Strophanthins / Q000627:therapeutic use; D014586:USSR
D002301:Cardiac Glycosides; D010666:Phenylpropionates; D010952:Plasma Substitutes; D013328:Strophanthins; D009277:Nandrolone; D000255:Adenosine Triphosphate
Primenenie nekotorykh serdechnykh glikozidov strofantinopodobnogo deĭstviia v farmakoterapii khronicheskoĭ nedostatochnosti krovoobrashcheniia.